Treatment of symptomatic intracranial atherosclerotic stenosis with a normal- sized gateway™ balloon and wingspan™ stent

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 1968-1974

  Yu, J ^a   Wang, L ^a   Deng, J P ^a   Li, J ^a   Gao, L ^a   Zhang, T ^a   Zhao, Z W ^a   Gao, G D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angioplasty; Balloon catheter; Gateway ; Intracranial atherosclerotic stenosis; Performance; Safety; Stent; Stroke; Wingspan

Indexed keywords

ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ATHEROSCLEROTIC STENOSIS; BRAIN INFARCTION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SAFETY; STENT; TREATMENT RESPONSE;

EID: 78650848024     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800610     Document Type: Article

References (16)

1. Wong KS, Huang YN, Gao S, et al: Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812-813.
2. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
3. Chimowitz MI, Kokkinos J, Strong J, et al: The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45: 1488-1493.
4. Mazighi M, Tanasescu R, Ducrocq X, et al: Prospectivestudyofsymptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006; 66: 1187-1191.
5. Fiorella D, Levy EI, Turk AS, et al: US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38: 881-887.
6. Bose A, Hartmann M, Henkes H, et al: A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007; 38: 1531-1537.
7. Henkes H, Miloslavski E, Lowens S, et al: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self- expanding stent deployment (WingSpan). Neuroradiology 2005; 47: 222-228.
8. Levy EI, Turk AS, Albuquerque FC, et al: Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61: 644-651.
9. Turk AS, Levy EI, Albuquerque FC, et al: Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008; 29: 23-27.
10. Samuels OB, Joseph GJ, Lynn MJ, et al: A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000; 21: 643-646.
11. Kasner SE, Chimowitz MI, Lynn MJ, et al: Predictors of ischemic stroke in the territory of a symptomatic intracranical arterial stenosis. Circulation 2006; 113: 555-563.
12. Amarenco P, Bogousslavsky J, Callahan A, et al: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559.
13. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure- lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
14. Fiorella D, Levy EI, Turk AS, et al: Target lesion revascularization after Wingspan: assessment of safety and durability. Stroke 2009; 40: 106-110.
15. SSYLVIA Study Investigators: Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35: 1388-1392.
16. Fiorella D, Chow MM, Anderson M, et al: A 7- year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007; 61: 236-243.